Manas Jaiswal of manasjaiswal.com has a buy call on Dr.
Reddy's Laboratories Ltd.
with a target price of Rs 2190.
The current market price of Dr.
Reddy's Laboratories Ltd.
is Rs 2127.15 Time period given by the analyst is Intra Day when Dr.
Reddy's Laboratories Ltd.
price can reach the defined target.
Manas Jaiswal recommended to keep stoploss at Rs 2095.
Dr.
Reddy's Laboratories Ltd., incorporated in 1984, is a largecap company with a market cap of Rs 35310.44 crore.Dr.
Reddy's Laboratories Ltd.
key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9586.80 Crore to Sales Value (98.63 % of Total Sales), Other Operating Revenue which contributed Rs 50.40 Crore to Sales Value (0.51 % of Total Sales), Licence Fees which contributed Rs 41.30 Crore to Sales Value (0.42 % of Total Sales), Scrap which contributed Rs 20.70 Crore to Sales Value (0.21 % of Total Sales) and Spent Chemicals which contributed Rs 20.60 Crore to Sales Value (0.21 % of Total Sales)for the year ending 31-Mar-2017.
For the quarter ended 30-06-2018, the company has reported a Consolidated sales of Rs 3650.70 Crore, up 3.28 % from last quarter Sales of Rs 3534.90 Crore and up 10.10 % from last year same quarter Sales of Rs 3315.90 Crore Company has reported net profit after tax of Rs 467.80 Crore in latest quarter.
The companys top management includes Dr.Ashok S Ganguly, Dr.Bruce L A Carter, Dr.Omkar Goswami, Mr.Anupam Puri, Mr.Bharat N Doshi, Mr.G V Prasad, Mr.K Satish Reddy, Mr.Sridar Iyengar, Ms.Kalpana Morparia.
Company has S R Batliboi Associates LLP as its auditoRs As on 30-06-2018, the company has a total of 165,973,228 shares outstanding.